Federal regulators are intensifying scrutiny of healthcare consolidation and AI-biotech ecosystems as physicians flee corporate systems to preserve clinical independence.
The Federal Trade Commission and Department of Justice are signaling a more aggressive stance toward market concentration as corporate giants move to consolidate control over outpatient surgery and medical data. Recent enforcement actions suggest the era of “manageable” regulatory costs for mega-mergers may be ending. This shift comes as bond yields reach 6% and U.S. government interest costs hit $1.2 trillion, placing pressure on regulators to ensure market competition remains a check against rising costs.
At the center of this shift is the scrutiny of Ascension’s $3.9 billion acquisition of AmSurg. While the deal added 250 ambulatory surgery centers (ASCs) to the nonprofit system’s portfolio, the FTC conditioned the merger on the divestiture of seven centers. More significantly, the pending consent order includes a 10-year prior-notice requirement for future acquisitions in five specific metropolitan areas. Legal analysts suggest this provision acts as a long-tail constraint, effectively chilling Ascension’s ability to further consolidate regional markets. By forcing a divestiture monitor and mandatory reporting, the FTC is signaling that structural remedies will be more rigorous than simple asset sell-offs.
This regulatory pressure coincides with a grassroots rebellion among medical professionals. Independent physicians are increasingly shifting case volumes to physician-owned surgery centers to avoid the centralized decision-making of massive hospital systems. As mergers centralize economic and clinical control, doctors are effectively voting with their feet to preserve autonomy. These independent centers are now viewed as a critical market counterweight, providing a competitive alternative to the institutional giants that have dominated the healthcare landscape for decades. The rise of these entities serves as a direct response to the consolidation of power that often leaves both doctors and patients with fewer choices.
The push for accountability extends to the intersection of AI and biotechnology. The recent success of a Merck-Moderna cancer vaccine has validated the $1.5 billion acquisition of Personalis by Tempus AI. While the market responded favorably, driving Tempus AI stock up by 24%, the resulting concentration of genomic data and intellectual property raises significant antitrust questions. To date, federal regulators have not announced formal inquiries into these AI-bio-pharma ecosystems, leaving a potential gap in oversight as data becomes the new currency of medical monopolies.
Beyond specific mergers, the DOJ is pursuing civil actions against restrictive hospital-insurer contracts, while the FTC recently reached a settlement regarding pharmacy benefit manager (PBM) pricing. These coordinated efforts reflect a strategy to dismantle barriers that entrench incumbent market power. Federal authorities have also urged state legislators to re-evaluate certificate-of-public-need (COPN) rules, arguing that such regulations often protect established monopolies rather than improve patient care.
As worker confidence declines due to AI uncertainty, the role of entrepreneurship has become a focal point for local leaders. On August 19, 2026, 116 mayors across 33 states committed to making small business growth a local priority. However, these local efforts face an uphill battle if federal regulators cannot prevent the further calcification of industry sectors. For the FTC and DOJ, the challenge remains whether structural remedies are enough to protect the free market from the gravity of absolute corporate power.
Greg Sanders serves as the Senior Correspondent for Corporate Power and Antitrust at Just Right News, where he brings a principled, conservative perspective to the complex intersection of big business, government regulation, and the American consumer. With a career dedicated to investigative depth and economic clarity, Greg has become a leading voice in examining how the consolidation of industry power impacts the foundational values of the free market and individual liberty.
Raised in Denver, Colorado, Greg’s reporting is deeply informed by the Western spirit of independence and a healthy skepticism of centralized authority. Growing up in the shadows of the Rockies, he witnessed firsthand the importance of local entrepreneurship and the vital role that small-medium enterprises play in sustaining vibrant communities. This upbringing instilled in him a belief that the American Dream is best preserved when the playing field remains level and when competition—rather than backroom deals between corporate lobbyists and federal regulators—dictates success. For Greg, the rugged individualism of his home state serves as a constant reminder that the economy should serve the people, not the other way around.
Now based in Chicago, Illinois, Greg operates from the heart of the nation’s industrial and financial crossroads. His location in the Midwest provides him with a unique vantage point to observe the real-world consequences of corporate overreach. From the boardrooms of the Loop to the manufacturing hubs that define the region, he tracks the movement of capital and the shifting tides of market influence. Chicago’s history as a center of trade and labor offers a rich backdrop for his work, allowing him to bridge the gap between high-level economic theory and the lived experiences of hardworking Americans who feel the squeeze of monopolistic practices.
At Just Right News, Greg’s beat focuses on the “new monopolies” and the rise of “woke” corporate culture. He argues that when corporations become too large, they often abandon their fiduciary duties to shareholders in favor of social engineering and political posturing. His reporting seeks to hold these “Titans” accountable, ensuring that the power of the purse is not used to silence dissent or bypass the democratic process. He is a firm advocate for the idea that true conservatism requires a vigilant defense of competition, preventing any single entity—public or private—from exerting undue control over the lives of citizens.
This mission is most clearly seen in his acclaimed feature series, “The Titans and the Toll.” In this ongoing project, Greg explores the human cost of market consolidation, from the erosion of consumer choice to the decline of local economies. Through rigorous analysis and boots-on-the-ground reporting, he documents how the concentration of power in sectors like tech, agriculture, and finance creates a “toll” paid by the average family.
Greg Sanders remains committed to the idea that a transparent, competitive market is the greatest engine for prosperity ever devised. Through his work at Just Right News, he continues to provide the essential oversight necessary to protect that engine from the encroaching influence of corporate giants and the bureaucratic structures that enable them.